1. Home
  2. UPC vs MIRA Comparison

UPC vs MIRA Comparison

Compare UPC & MIRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Universe Pharmaceuticals Inc.

UPC

Universe Pharmaceuticals Inc.

HOLD

Current Price

$4.77

Market Cap

3.3M

Sector

Health Care

ML Signal

HOLD

Logo MIRA Pharmaceuticals Inc.

MIRA

MIRA Pharmaceuticals Inc.

HOLD

Current Price

$0.77

Market Cap

32.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UPC
MIRA
Founded
1998
2020
Country
China
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.3M
32.1M
IPO Year
2020
2023

Fundamental Metrics

Financial Performance
Metric
UPC
MIRA
Price
$4.77
$0.77
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
98.6K
1.5M
Earning Date
01-29-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.00
$0.60
52 Week High
$17.96
$2.45

Technical Indicators

Market Signals
Indicator
UPC
MIRA
Relative Strength Index (RSI) 50.07 52.12
Support Level $2.51 $0.72
Resistance Level $4.78 $0.82
Average True Range (ATR) 0.53 0.08
MACD 0.04 0.00
Stochastic Oscillator 62.18 20.47

Price Performance

Historical Comparison
UPC
MIRA

About UPC Universe Pharmaceuticals Inc.

Universe Pharmaceuticals Inc is a pharmaceutical company specializing in the manufacturing, marketing, sales and distribution of traditional Chinese medicine derivatives products targeting the elderly with the goal of addressing their physical conditions in the ageing process and promoting their general well-being. The company also sells biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces, and dietary supplements manufactured by third-party pharmaceutical companies. Its products are under two categories namely treatment and relief for common chronic health conditions in the elderly designed to achieve physical wellness and longevity (Chronic Condition Treatments), and cold and flu medications.

About MIRA MIRA Pharmaceuticals Inc.

Mira Pharmaceuticals Inc is a clinical-stage pharmaceutical development company focused on developing novel oral small-molecule therapeutics for neurologic, neuropsychiatric, metabolic, and inflammatory disorders. The company's pipeline includes three product candidates: Ketamir-2, MIRA-55, and SKNY-1, three drug candidates designed to address unmet medical needs across neuropathic and inflammatory pain, central nervous system disorders, and metabolic and behavioral conditions. The company operates as a single operating and reportable segment.

Share on Social Networks: